BWX Technologies (BWXT) Stock Expands Nuclear Capabilities with Precision Components Acquisition

Table of Contents BWX Technologies (NYSE: BWXT) is strategically expanding its commercial nuclear operations through the acquisition of Precision Components Group. BWX Technologies, Inc., BWXT Revealed on April 20, this transaction will incorporate PCG along with its operating subsidiaries—Precision Custom Components and DC Fabricators—into BWXT’s organizational structure. PCG will become part of BWXT’s Commercial Operations division while maintaining operations at its current production sites. According to BWXT, this strategic move delivers more than 500,000 square feet of domestic heavy-manufacturing infrastructure. The acquisition also integrates a highly trained workforce exceeding 400 employees. PCG generated approximately $125 million in annual revenue, representing a substantial addition to BWXT’s financial performance. Company leadership positions this acquisition as an initial phase in expanding domestically-based commercial nuclear manufacturing capabilities. According to John MacQuarrie, President of Commercial Operations at BWXT, the deal “builds on BWXT’s strong performance in the commercial nuclear industry” and addresses “the accelerating needs of US commercial nuclear customers.” BWXT entered this acquisition from a position of financial strength. The company surpassed analyst projections in its latest reporting period, delivering EPS of $1.08 versus the consensus estimate of $0.91. Revenue reached $885.8 million, exceeding the anticipated $837.5 million. This revenue represented an 18.7% increase compared to the previous year, and across fiscal 2025, BWXT achieved 18% total revenue growth to $3.19 billion. Earnings per share expanded 20% during the same timeframe with a net profit margin of 10.3%. Looking ahead to FY2026, management established EPS guidance ranging from $4.55 to $4.70. Market analysts maintain a consensus “Moderate Buy” recommendation with an average price target of $207.60. BWXT stock commenced trading Friday at $223.54, positioned above both its 50-day moving average of $211.42 and its 200-day moving average of $198.99. The stock trades within a 52-week range spanning $102.42 to $241.82 and maintains a market capitalization of $20.48 billion. The company also incrementally increased its quarterly dividend from $0.25 to $0.27, equating to an annualized $1.08 with approximately 0.5% yield. Institutional stakeholders control approximately 94.39% of BWXT shares. Multiple major investment firms expanded their positions during recent quarters. Alkeon Capital Management increased its holdings by 163% in Q3, accumulating over 1.57 million shares valued at roughly $291 million. Invesco boosted its stake by 60.1% to surpass 2.5 million shares. B. Metzler seel. Sohn & Co. AG established a new position during Q4, acquiring 9,481 shares worth approximately $1.64 million. Conversely, company insiders reduced holdings by roughly 13,327 shares totaling $2.73 million throughout the previous 90 days. CAO Kevin James Gorman divested 1,344 shares in early March at an average price of $214.71. Insider ownership currently represents about 0.60% of total shares. Regarding analyst perspectives, Wells Fargo launched coverage with an “underweight” designation and $200 price objective. TD Cowen assigned a “buy” rating with a $230 target. Zacks Research elevated BWXT from “hold” to “strong-buy” status in January. BWXT maintains its position as the exclusive provider of naval nuclear reactors for US submarines and aircraft carriers, having manufactured over 400 naval reactors since the commissioning of the USS Nautilus.